An open-label, noncomparative study of miglustat in type I Gaucher disease: Efficacy and tolerability over 24 months of treatment
- 31 August 2005
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (8), 1215-1227
- https://doi.org/10.1016/j.clinthera.2005.08.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Functional Tests to Quantify Recovery Following Carpal Tunnel ReleaseJournal of Hand Therapy, 2005
- Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapyBlood, 2004
- Enzyme therapy of gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies☆ ☆This study was supported by NIH Grant R01 DK 36729 to GAG.Blood Cells, Molecules, and Diseases, 2003
- Anaphylactoid Reaction to Imiglucerase, but Not to Alglucerase, in a Type I Gaucher PatientBlood Cells, Molecules, and Diseases, 1999
- Gaucher DiseaseMedicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- The hopkins verbal learning test: Development of a new memory test with six equivalent formsThe Clinical Neuropsychologist, 1991
- Predicting premorbid IQ: A revision of the national adult reading testThe Clinical Neuropsychologist, 1989
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975
- The Purdue Pegboard: norms and studies of reliability and validity.Journal of Applied Psychology, 1948